《大行》中金升上美股份(02145.HK)目標價至98元 業績預告超預期
中金發表報告指,維持上美股份(02145.HK)「跑贏行業」評級,業績預告超預期,多品牌集團前景可期。考慮到品牌勢能持續釋放、競爭優勢不斷增強,上調2025至2026年淨利潤預測13%與13%,至11.3億及13.9億元人民幣,上調目標價15%至98港元。
報告指,上美股份預計上半年收入40.9億至41.1億元人民幣,按年增16.8%至17.3%;淨利潤5.4億至5.6億元人民幣,按年增30.9%至35.8%;取區間中值計算,對應上半年淨利率13.4%。預告利潤超出預期,主因公司渠道及品牌結構優化帶動利潤率提升超預期。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.